Ftse Mib
39.066,50
1,06%
DAX
23.109,26
2,73%
S&P 500
5.954,50
1,59%
NASDAQ
18.847,28
0,00%
Bitcoin
92.924,62
-1,40%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Imunon Inc (IMNN) Imunon Inc (IMNN) Notizie

Imunon Inc

IMNN
0,899
0,0083 (0,93%)
Pre Mercato
Ultimo aggiornamento: 13:00:14
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/2/202514:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202514:10EDGAR2Form 8-K - Current report
27/2/202514:05GLOBEIMUNON Reports 2024 Financial Results and Provides Business..
26/2/202514:05GLOBEIMUNON Announces New Immunogenicity Data from Phase 1..
20/2/202514:30GLOBEIMUNON to Hold 2024 Financial Results and Business Update..
19/2/202522:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/2/202514:05GLOBEIMUNON Announces Translational Data from Phase 1/2 OVATION 2..
18/2/202522:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/2/202519:50EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
10/2/202514:10EDGAR2Form 8-K - Current report
10/2/202514:05GLOBEIMUNON Appoints Douglas V. Faller, M.D., Ph.D., as Chief..
28/1/202522:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202414:05GLOBEIMUNON Announces Positive CMC Meeting with FDA for IMNN-001..
10/12/202414:05GLOBEIMUNON Announces Continued Strong Improvement in Overall..
27/11/202422:30EDGAR2Form 8-K - Current report
25/11/202414:05GLOBEIMUNON Announces Results from its End-of-Phase 2 Meeting..
14/11/202423:37EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
14/11/202418:17EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202416:00GLOBEIMUNON Presents Positive Data from Phase 2 OVATION 2..
07/11/202415:05EDGAR2Form 8-K - Current report
07/11/202415:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202414:05GLOBEIMUNON Reports Third Quarter 2024 Financial Results and..
01/11/202400:57EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
31/10/202413:30GLOBEIMUNON to Hold Third Quarter 2024 Financial Results and..
30/10/202414:05GLOBEIMUNON to Present Phase 2 Data of IMNN-001 in Treatment of..
08/10/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/10/202414:10EDGAR2Form 8-K - Current report
07/10/202414:05GLOBEIMUNON Reports Inducement Grant Under NASDAQ Listing Rule..
27/9/202422:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
20/9/202422:05EDGAR2Form S-1/A - General form for registration of securities..
10/9/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202422:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202422:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202422:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202422:06GLOBEUPDATE - IMUNON’s Ovarian Cancer R&D Day to Feature..
09/9/202414:30GLOBEIMUNON’s Ovarian Cancer R&D Day to Feature Presentations..
03/9/202414:10EDGAR2Form 8-K - Current report
03/9/202413:52EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
29/8/202415:58EDGAR2Form S-1 - General form for registration of securities under..
29/8/202415:28EDGAR2Form S-8 - Securities to be offered to employees in employee..
28/8/202414:30GLOBEIMUNON to Host R&D Day on September 18th
16/8/202414:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202414:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202415:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202414:05EDGAR2Form 8-K - Current report
14/8/202414:00GLOBEIMUNON Reports Second Quarter 2024 Financial Results and..
Apertura: Min: Max:
Chiusura: 0,8907

La tua Cronologia

NASDAQ
IMNN
Imunon
ASX
MOHNB
Moho Resources NL
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci